Hypoglycaemia and cardiovascular Risk in Type 2 Diabetes

被引:0
|
作者
Kahl, S. [1 ]
机构
[1] Heinrich Heine Univ, Deutsch Diabet Zentrum, Inst Klin Diabetol, Leibniz Zentrum Diabet Forsch, Auf' Hennekamp 65, D-40225 Dusseldorf, Germany
来源
DIABETOLOGE | 2021年 / 17卷 / 08期
关键词
LIRAGLUTIDE;
D O I
10.1007/s11428-021-00832-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:822 / 824
页数:3
相关论文
共 50 条
  • [41] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Zarich, Stuart W.
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (09) : 500 - 506
  • [42] Renal dysfunction and cardiovascular risk in Type 2 diabetes
    Shah, I. M.
    Ghosh, A. K.
    Collier, A.
    DIABETIC MEDICINE, 2007, 24 : 15 - 16
  • [43] Interview Cardiovascular Risk Reduction for Type 2 Diabetes
    Leitner, H.
    JOURNAL FUR KARDIOLOGIE, 2019, 26 (3-4): : 92 - 94
  • [44] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Stuart W. Zarich
    Nature Reviews Endocrinology, 2009, 5 : 500 - 506
  • [45] Cardiovascular disease risk stratification in type 2 diabetes
    Esdaile, Harriet
    Mayet, Jamil
    Hill, Neil
    DIABETIC MEDICINE, 2022, 39 (10)
  • [46] Risk Prediction of Cardiovascular Disease in Type 2 Diabetes
    Cederholm, Jan
    Eeg-Olofsson, Katarina
    Eliasson, Bjoern
    Zethelius, Bjoern
    Nilsson, Peter M.
    Gudbjornsdottir, Soffia
    DIABETES CARE, 2008, 31 (10) : 2038 - 2043
  • [47] CARDIOVASCULAR RISK STRATIFICATION IN TYPE 2 DIABETES IN ITALY
    Manicardi, V.
    Pintaudi, B.
    Piscitelli, G.
    Frison, V.
    Corrao, S.
    Graziano, G.
    Rossi, M.
    Nicolucci, A.
    Gallo, M.
    Scatena, A.
    Mannino, D.
    Di Bartolo, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C87 - C87
  • [48] Microalbuminuria as a cardiovascular risk factor in type 2 diabetes
    Kashiwagi, Atsunori
    Araki, Shin-ichi
    ENDOCRINE JOURNAL, 2010, 57 : S217 - S217
  • [49] Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes
    Motairek, Issam
    Al-Kindi, Sadeer
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 135 - 147
  • [50] Type 2 diabetes mellitus is not a cardiovascular risk equivalent
    Saely, CH
    Marte, T
    Aczel, S
    Langer, P
    Koch, L
    Schmid, F
    Drexel, H
    DIABETES, 2005, 54 : A182 - A183